“Research is always a lot of failures and a few successes”

Gene therapies open up fantastic possibilities, but they are also extremely expensive to produce. Genenova aims to change that and make the treatments accessibl...

”We need compatibility“

Penilla Gunther, founder of Fokus Patient and chair of the European Patient Safety Foundation, hopes that the forthcoming life science strategy will focus on ef...

Ny ordförande för Atlas Antibodies

Åsa Riisberg, styrelseproffs och tidigare partner i EQT, tar över ordförandeklubban i Atlas Antibodies.

Drug development creates new challenges for regulators

New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Stockholm (2026)

Astra Zeneca faces potential multimillion-dollar fines in China

Astra Zeneca could be forced to pay up up to $8 million in fines for allegedly unpaid import duties in China, as the company seeks to rebuild trust following ea...

Samuel Lagercrantz: ”Will the Swedish life science strategy be updated with precision?”

What will the Swedish government focus on in the life science strategy that is being updated? And what should be prioritized in the strategy? Life Science Swede...

Investigations against AstraZeneca: ”Chinese interests may be behind them”

Why are there several investigations against AstraZeneca employees in China right now? Life Science Sweden continues to seek answers.

“Conducting research at universities is becoming more and more like working at a research hotel”

The government wants Swedish research to focus on excellence and innovation, but can the two be combined? Life Science Sweden talks to Anna Falk, a professor at...

Roche’s Genentech terminates licencing deal with Norwegian biotech

Genentech is ending a license collaboration with Norwegian biotech Nykode Therapeutics regarding a clinical stage cancer vaccine program.

Success for Genmab's antibody-drug conjugate

The Danish company Genmab has received Japanese approval for its treatment for advanced or recurrent cervical cancer.

One last chance to register for the premier metrology event in 2024

ZEISS QUALITY INNOVATION SUMMIT.

Giulia Gaudenzi: Innovation for good

"I challenge the innovator landscape to take a mental leap. Relying on innovation-solely to end inequality is not enough, therefore consciously and purposively ...

Joy at Egetis after positive CHMP opinion – ”The single most important milestone”

Stockholm-based Egetis Therapeutics has received a positive CHMP opinion for Emcitate, which could become the first approved treatment for the rare disease MCT8 deficiency."

Achieve Efficient, Fast Targeting of Your Sample

Step into the future of imaging technology with VersaXRM 730.

AstraZeneca to use American AI platform for cancer trials

In a collaboration AstraZeneca will use an AI model from Israeli-American biotech Immunai to streamline its clinical trials in cancer.

Han blir Chalmers nya rektor

Martin Nilsson Jacobi har utsetts till ny rektor och vd för Chalmers tekniska högskola. Han är idag vd för Chalmersstiftelsen och har en lång bakgrund inom lärosätet.

Are you curious about volume imaging for very large samples?

Exciting ZEISS Webinar!

Cellink i samarbete med MIT

Det svenska 3D-printingbolaget ingår i flera projekt tillsammans med Robert S Langers forskningslaboratorium vid MIT.

After the threat of tariffs – Novartis invests 230 billion in the USA

Pharmaceutical giant Novartis plans to invest 23 billion dollarsover the next five years to expand its production in the USA. The goal is for all medicines dest...

CTC Clinical Trial Consultants AB

A small thing that can solve your problems

If you are in need of a compact valve. Look no further! We have the VOVK

Astra Zeneca licensierar ut Crispr-teknologi

Det amerikanska Crispr-bolaget Synthego kommer att få tillgång till ett genredigeringsenzym från Astra Zeneca genom ett nytecknat licensavtal.

Transportera och reglera vätskor, gaser och fasta medier

När det gäller att transportera och reglera vätskor, gaser och fasta medier så säkert som möjligt spelar ventiler och regleringsenheter från vår tillverkare Int...